Register entry
Luoxin Aurovitas Pharma (Chengdu) Co., Ltd.
Data as of · How to read this entry
- Registered sites
- 1
- Active NDC listings
- 6
- Live patents
- 0
- Countries
- 1
- Base
- China
Authorisation
Registered operations
Analytical testing1Finished drug manufacture1
Sites
Registered establishments
1| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| Luoxin Aurovitas Pharma (Chengdu) Co., Ltd. | No.800, Haifa Road, Chengdu Cross-strait Science and Technology Industrial Development Park, Wenjiang District, Chengdu, Sichuan 611130, China (CHN) | Analytical testing, Finished drug manufacture | 3019967180404080894 |
Catalogue
Drug listings by form and route
66 active NDC listings: 6 human prescription drug. By marketing category: ANDA 6.
| Dosage form | NDCs |
|---|---|
| solution | 6 |
| Route | NDCs |
|---|---|
| respiratory (inhalation) | 6 |
| Labeller name on the listing | NDCs |
|---|---|
| luoxin aurovitas pharma (chengdu) co., ltd. | 6 |
Catalogue
Marketed products
6| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| ALBUTEROL SULFATE | ALBUTEROL SULFATE | solution, respiratory (inhalation) | 81894-104ANDA |
| ALBUTEROL SULFATE | ALBUTEROL SULFATE | solution, respiratory (inhalation) | 81894-105ANDA |
| ALBUTEROL SULFATE | ALBUTEROL SULFATE | solution, respiratory (inhalation) | 81894-106ANDA |
| Levalbuterol | Levalbuterol | solution, respiratory (inhalation) | 81894-101ANDA |
| Levalbuterol | Levalbuterol | solution, respiratory (inhalation) | 81894-102ANDA |
| Levalbuterol | Levalbuterol | solution, respiratory (inhalation) | 81894-103ANDA |
Neighbours
Registered in the same town
6- PCI Pharma Services Canada, Inc.Chengdu, CHN
- Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.Chengdu, CHN
- Zennova LLCChengdu, CHN
- Chengdu Brilliant Biopharmaceutical Co., Ltd.Chengdu, CHN
- Chengdu Shuode Pharmaceutical Co.,LtdChengdu, CHN
- Chengdu Suncadia Medicine Co., Ltd.Chengdu, CHN
Compare
Comparable companies in China
- Kingkey MBC Life Technology Group co., LTD.1 site · 158 NDC
- Zhejiang Guoyao Jingyue Aerosol Co Ltd1 site · 94 NDC
- Shenzhen iShan Technology Co Ltd1 site · 84 NDC
- Xiamen Kang Zhongyuan Biotechnology Co., Ltd.1 site · 68 NDC
- Changzhou Maokang Medical Products Co., Ltd1 site · 59 NDC
- Jianerkang Medical Co Ltd1 site · 56 NDC
- Humanwell PuraCap Pharmaceuticals (Wuhan) Co., Ltd1 site · 40 NDC
- Guangdong Aimu Biological Technology Co Ltd1 site · 39 NDC
- Shenzhen Xinxin Yunhai Technology Co., Ltd.1 site · 37 NDC
- Guangdong Quadrant Ecological Technology Co., Ltd.1 site · 35 NDC
Enquiry
Common questions
- Is Luoxin Aurovitas Pharma (Chengdu) Co., Ltd. FDA approved?
- Luoxin Aurovitas Pharma (Chengdu) Co., Ltd. holds 1 FDA-registered establishment in China. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are Luoxin Aurovitas Pharma (Chengdu) Co., Ltd.'s drugs manufactured?
- The FDA register lists Chengdu. Registered operations: analytical testing, finished drug manufacture.
- What drugs does Luoxin Aurovitas Pharma (Chengdu) Co., Ltd. make?
- 6 products are listed under Luoxin Aurovitas Pharma (Chengdu) Co., Ltd. in the openFDA NDC Directory, most often as solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.